Study on patient experiences for osteosarcoma clinical trials
Part of Cancer clinical trials.
This study asks people with osteosarcoma about what it’s like to join and participate in clinical trials. It may help improve how future trials are explained and run.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with osteosarcoma
- You are planning to enroll in an interventional clinical trial
- You are at least 18 years old
- You are not currently pregnant
- You can understand, sign, and return the informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on improving how osteosarcoma care is coordinated and delivered, using collaboration between clinicians. It may help by helping teams make more consistent treatment decisions for people newly diagnosed.
This trial is a registry that collects health and medical history from people with osteosarcoma and related bone cancers. It may help researchers learn how these cancers behave and support better future studies.
This study is watching people whose high-grade osteosarcoma came back in the same bone area (local relapse) after treatment. It helps doctors understand how local relapse happens, so they can improve future care.
This trial uses a lab-grown mini tumor (organoid) from your biopsy to test which drugs might work best for your osteosarcoma. It aims to personalize your treatment based on how your specific cancer cells respond.
This trial studies why people with chondrosarcoma choose to join or not join clinical trials. It collects information through regular electronic reports to improve future cancer research.
This study asks people with osteoporosis about what it’s like to join and go through clinical trials. Your feedback may help improve how future osteoporosis studies are done and supported.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.